Non-smokers with lung cancer respond better to treatment than smokers, study says

April 24, 2006

Smoking history contributes to poor outcomes in the treatment of lung cancer, according to a new study. Non-small cell lung cancer (NSCLC) lung cancer patients who have never smoked before in their life have better overall survival rates and respond better to chemotherapy than current or former smokers. Published in the June 1, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study also reveals that smoking status during treatment has no affect on clinical outcome.

Cigarette smoking is the most significant risk factor for developing lung cancer, one of most common and aggressive malignancies in the world. In 2005, over 170,000 Americans were diagnosed with lung cancer and over 160,000 patients died. The five-year survival rate from lung cancer is less than 20 percent at best. NSCLC causes the majority of lung cancers, and if cured, the survivor has up to a 4 percent annual risk of developing another tumor.

Despite the association of lung cancer with cigarettes, diagnosed patients continue to smoke. However, physicians remain unable to tell their patients how that will impact their cancer treatment. Previous studies have failed to agree on whether smoking status impacts the outcome of chemotherapy or chemotherapy and thoracic irradiation.

Led by Anne S. Tsao, M.D. of the University of Texas M. D. Anderson Cancer Center in Houston, researchers reviewed the medical records of 1370 patients with NSCLC who were treated with chemotherapy or chemo-radiation to determine an association between smoking and treatment response and survival.

The researchers found that patients who never smoked had a better response to the chemotherapy; developed less disease progression during therapy; and showed improved survival over former and current smokers. They say the finding may be due to non-smokers having less genetic damage compared to smokers, being less likely to have other ailments that would affect survival, and having better preserved lung function. The authors write that "Continued efforts at preventing smoking initiation are a critical public health issue and emphasize the need for chemoprevention for smokers and primary-prevention protocols to prevent smoking."
-end-
Article: "Smoking Affects Treatment Outcome in Patients with Advanced Nonsmall Cell Lung Cancer," Anne S. Tsao, Diane Liu, J. Jack Lee, Margaret Spitz, Waun Ki Hong, CANCER; Published Online: April 24, 2006 (DOI: 10.1002/cncr.218844); Print Issue Date: June 1, 2006.

Wiley

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.